A microarray configuration to quantify expression levels and relative abundance of splice variants

被引:51
作者
Fehlbaum, P [1 ]
Guihal, C [1 ]
Bracco, L [1 ]
Cochet, O [1 ]
机构
[1] ExonHit Therapeut, F-75013 Paris, France
关键词
D O I
10.1093/nar/gni047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the past decade, alternative RNA splicing has raised a great interest appearing to be of high importance in the generation of expression diversity. This regulatory process plays a critical role in the normal development and its impact on the initiation and development of human disorders as well as on the pharmacological properties of drugs is increasingly being recognized. Only few studies describe specific alternative splicing expression profiling. Microarray strategies have been conceived to address alternative splicing events but with very few experimental data related to their abilities to provide true quantification values. We have developed a specific microarray configuration relying on a few, well optimized probes per splice event. Basically, five probes of 24mer are used to fully characterize a splice event. These probes are of two types, exon probes and junction probes, and are either specific to a splice event or not. The performances of such a 'splice array' were validated on synthetic model systems and on complex biological materials. The results indicate that DNA chips based on this design combining exon and junction derived probes enable the detection and, absolute and relative quantification of splice variants. In addition, this strategy is compatible with all the microarrays that use oligonucleotide probes.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 48 条
[1]   Identification of cis-elements regulating exon 15 splicing of the amyloid precursor protein pre-mRNA [J].
Bergsdorf, C ;
Paliga, K ;
Kreger, S ;
Masters, CL ;
Beyreuther, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :2046-2056
[2]   Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy [J].
Brichta, L ;
Hofmann, Y ;
Hahnen, E ;
Siebzehnrubl, FA ;
Raschke, H ;
Blumcke, I ;
Eyupoglu, IY ;
Wirth, B .
HUMAN MOLECULAR GENETICS, 2003, 12 (19) :2481-2489
[3]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[4]   Correction of disease-associated exon skipping by synthetic exon-specific activators [J].
Cartegni, L ;
Krainer, AR .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (02) :120-125
[5]   Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing [J].
Castle, J ;
Garrett-Engele, P ;
Armour, CD ;
Duenwald, SJ ;
Loerch, PM ;
Meyer, MR ;
Schadt, EE ;
Stoughton, R ;
Parrish, ML ;
Shoemaker, DD ;
Johnson, JM .
GENOME BIOLOGY, 2003, 4 (10)
[6]   Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays [J].
Clark, TA ;
Sugnet, CW ;
Ares, M .
SCIENCE, 2002, 296 (5569) :907-910
[7]   Finishing the euchromatic sequence of the human genome [J].
Collins, FS ;
Lander, ES ;
Rogers, J ;
Waterston, RH .
NATURE, 2004, 431 (7011) :931-945
[8]   Alternate splice-site utilization in the gene for the catalytic subunit of the DNA-activated protein kinase, DNA-PKcs [J].
Connelly, MA ;
Zhang, H ;
Kieleczawa, J ;
Anderson, CW .
GENE, 1996, 175 (1-2) :271-273
[9]   Determinants of 4-repeat tau expression - coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion [J].
D'Souza, I ;
Schellenberg, GD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) :17700-17709
[10]   Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients [J].
Darreh-Shori, T ;
Hellström-Lindahl, E ;
Flores-Flores, C ;
Guan, ZZ ;
Soreq, H ;
Nordberg, A .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (05) :1102-1113